Expert opinion about the use of transdermic oxybutynin in Spain for the treatment of adult overactive bladder

Autor: Muller-Arteaga, C, Guzman, SA, Gomez, MFL, Errando-Smet, C, Lopez, RG, Santos, JC, Banos, JLG, Marcos, MS, Gamiz, AO, Salas, SM, Rodriguez, RM, Grasa, IO

Publikováno v: Archivos espanoles de urologia
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname

OBJECTIVES: To define the different characteristics of transdermal oxybutynin (TO) for the treatment of overactive bladder in adults, to know the barriers for the use of this drug and to establish proposals to minimize these barriers. METHODS: Local

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::3134070fc22f45107615cd2ed75128dd
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=9360